Best Life Sciences Platforms and Tools Companies in United States

#1

Life Biosciences Series D

location_onBoston, Massachusetts

Biotechnology pioneering cellular rejuvenation therapies to reverse and prevent aging diseases. The company is focused on targeting the biology of aging, which is the biggest risk factor for most chronic diseases. They are developing a novel partial epigenetic reprogramming platform that targets a key underlying mechanism of aging to prevent and reverse age-related diseases with significant unmet need to extend healt

#2

Cellares Series D

location_onSan Francisco, California

Manufacturer of a medical device for cell-based therapy. The company offers Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. It also, offers software suite for cell therapy modalities.

#3

Alamar Biosciences Public

location_onFremont, California

Provider of solutions for ultra-high sensitivity protein analysis across a range of multiplex levels. The company's proprietary NULISA Chemistry utilizes a novel sequential capture and release method that significantly reduces background signal and increases the sensitivity and dynamic range compared with standard approaches and allows both qPCR and NGS readouts. Applications include clinical assay development, bioma

#4

Opentrons Unicorn Series C

location_onBrooklyn, New York

Developer of pipetting robot for lab automation. The company's product OT-2 personal pipetting robot uses manual micro-pipettes to transfer fluids and automates the repetitive benchwork associated with lab activities. It also has scalable hardware and software and is developed in an open-source manner.

#5

SpectronRx Series C

location_onIndianapolis, Indiana

SpectronRx is a provider of therapeutic and diagnostic isotope solutions. It provides radionuclides and custom theranostic contract manufacturing like monoclonal antibody labelling, peptides, radiolabeling of molecules and chemical entities, and aptamers.

#6

Antheia Series C

location_onPalo Alto, California

Antheia is focused on developing medicines using its technology. Its technology combines synthetic biology, informatics, and fermentation technology to provide plant-based medicines. It is currently working on engineering the yeast cells genetically to produce natural medicinal products.

#7

PrognomiQ Series D

location_onSan Mateo, California

Developer of tests for the detection and treatment of cancer and other diseases. The company's products use proteomic data with genomic, metabolomic, and other health data for early disease detection.

#8

Quiver Bioscience Acquired

location_onCambridge, Massachusetts

Developer of transformational medicines for neurological disorders. The company combines advanced human cellular models, unique measurement engineering, artificial intelligence, and machine learning into a proprietary platform to discover new drugs for neurological disease. The company's lead candidate is UBE3A for Seizure and Neurodevelopment Disorders.

#9

Emulate Series E

location_onBoston, Massachusetts

Developer of in vitro models for drug development. The company has culture modules, organ-chips, and analytical software applications. The proprietary Organ-Chip models including the liver, intestine, kidney, and others contain tiny hollow channels lined with tens of thousands of living human cells and tissues are designed to predict human response.

#10

Culture Biosciences Series C

location_onSan Francisco, California

Provider of biomanufacturing hardware and software tools for research purposes. They have developed the digital biomanufacturing platform by integrating automated bioreactors, robotic sample handling, and cloud data monitoring. It offers services such as strain screening, media optimization, and process development.

#11

Dewpoint Therapeutics Series D

location_onBoston, Massachusetts

Dewpoint Therapeutics is involved in development of small molecules based therapeutics. The company offers condensate biology to create dynamic, liquid compartments in cells for the treatment of neurodegeneration, cancer, and other diseases.

#12

Avalon Globocare Public

location_onFreehold, New Jersey

Avalon GloboCare is involved in developing exosome technology. They have developed core platforms, namely Avalon Cell and Avalon Rehab for early detection of oral cancer (saliva exosomes), ovarian cancer (plasma exosomes), kidney cancer (urine exosomes), skin regeneration, anti-fibrosis, treatments of degenerative disorders such as Alzheimer’s disease, arthritis, osteoporosis, etc.